All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MDS Alliance.

The MDS Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Antibody therapy

Antibody therapy

Monoclonal antibodies target antigens expressed predominantly by leukemic cells, making them more selective than chemotherapy. Antibodies induce an immune response to destroy cancer cells or block key extracellular sites such as receptors to cause cancer cell death. Some promising targets for antibody-based therapy in MDS are CD33, CD45, CD47, and CD123.

|||